IBRIA was established to provide quality services in research and development of medicines which involves both pre-clinical and clinical elements. At pre-clinical level, we provide technical guidance to the biomedical scientists on quality, safety and efficacy assessments. We specialise in all aspects of the clinical evaluation of new medicines. 

We develop clinical protocols, manage clinical trials, train clinical trial investigators on Good Clinical Practice, etc. In view of our expertise in this field, we have been engaged by the World Health Organization Regional Office for Africa to develop clinical protocols for the evaluation of new phytomedicines developed by African scientists. We have developed phytomedicines from both medicinal plants and food plants for treatment of sickle cell anaemia, malaria, peptic ulcer. Currently, we are involved with research and development of new phytomedicines for the treatment of breast, colon, prostate and cervical cancers as well as diabetes.